In our results, we demonstrated that repeated EA intervention ameliorates DSS-induced colitis by suppressing proinflammatory mediators, including CRP, IFN-γ, TNF-α, and IL-6 through the TLR4 signaling via MyD88-dependent pathway. The gene discussed is MYD88; the disease is colitis.